RISK OF MALIGNANCY AND SEVERE INFECTION IN A POPULATION OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICS OR DMARDS

被引：0
|
作者：
Gilliaux, Q. [1 ]
Stoenoiu, M. [1 ]
de Bellefon, L. Meric [1 ]
Depresseux, G. [1 ]
Toukap, A. Nzeusseu [1 ]
Lauwerys, B. [1 ]
Houssiau, F. [1 ]
Durez, P. [1 ]
机构：
[1] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Rheumatol,Serv & Pole Rhumatol, Brussels, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0163
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [41] BIOLOGICS THERAPY FOR PATIENTS WITH RHEUMATOID ARTHRITIS AND HEPATITIS B INFECTION
    Tada, M.
    Koike, T.
    Tamori, A.
    Okano, T.
    Sugioka, Y.
    Mamoto, K.
    Inui, K.
    Nakamura, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 430 - 430
  • [42] RISK OF MALIGNANCIES ASSOCIATED WITH CS DMARDS IN RHEUMATOID ARTHRITIS: COMPARISON WITH GENERAL POPULATION AND BIOLOGIC TREATED PATIENTS (ANALYSIS OF A NATIONAL CLAIM DATABASE)
    Seror, R.
    Lafourcade, A.
    De-Rycke, Y.
    Fautrel, B.
    Mariette, X.
    Tubach, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 287 - 287
  • [43] Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study
    Dreyer, Lene
    Cordtz, Rene L.
    Hansen, Inger Marie J.
    Kristensen, Lars Erik
    Hetland, Merete L.
    Mellemkjaer, Lene
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (04) : 510 - 514
  • [44] Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: an updated meta-analysis
    Olsen, Catherine M.
    Green, Adele C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (08)
  • [45] Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
    Richter, A.
    Listing, J.
    Schneider, M.
    Klopsch, T.
    Kapelle, A.
    Kaufmann, J.
    Zink, A.
    Strangfeld, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1667 - 1673
  • [46] Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
    Germano, Valentina
    Cattaruzza, Maria Sofia
    Osborn, John
    Tarantino, Aurora
    Di Rosa, Roberta
    Salemi, Simonetta
    D'Amelio, Raffaele
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [47] Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
    Valentina Germano
    Maria Sofia Cattaruzza
    John Osborn
    Aurora Tarantino
    Roberta Di Rosa
    Simonetta Salemi
    Raffaele D’Amelio
    Journal of Translational Medicine, 12
  • [48] Risk of Mortality, Fatal Infection, and Fatal Malignancy Related to Use of Anti-Tumor Necrosis Factor-α Biologics by Rheumatoid Arthritis Patients
    Thyagarajan, Veena
    Norman, Heather
    Alexander, Kimberly A.
    Napalkov, Pavel
    Enger, Cheryl
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (03) : 223 - 233
  • [49] Cancer risk with biologic DMARDs in rheumatoid arthritis
    Reactions Weekly, 2017, 1672 (1) : 11 - 11
  • [50] Aseptic pyomyositis in rheumatoid arthritis treated with corticosteroid and DMARDs
    Karmacharya, Sudhir
    Shrestha, Adheep Arun
    Nakarmi, Shweta
    Bhochhibhoya, Manisha
    Vaidya, Binit
    OXFORD MEDICAL CASE REPORTS, 2024, 2024 (06): : 245 - 248
12345